SCHEMBL28603

SCHEMBL28603

O=C1CCc2cc(Cl)ccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.59
CASP7 P55210 1/20 0.59
HSD17B10 Q99714 1/20 0.59
SRD5A1 P18405 3/20 0.55
SRD5A2 P31213 2/20 0.55
HTT P42858 1/20 0.53
HSD17B1 P14061 2/20 0.52
MAOA P21397 2/20 0.50
MAOB P27338 2/20 0.50
PRKCI P41743 1/20 0.50
GRM5 P41594 1/20 0.49
METAP1 P53582 1/20 0.48
VHL P40337 1/20 0.47
ELOC Q15369 1/20 0.47
ELOB Q15370 1/20 0.47
S100A4 P26447 1/20 0.46
TYMS P04818 1/20 0.46
CYP11B1 P15538 3/20 0.45
CYP11B2 P19099 3/20 0.45
CYP19A1 P11511 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31029247 1.00 CASP1 (0.59) CASP1CASP7HSD17B10SRD5A1SRD5A2
Hydrochloric Acid SCHEMBL28688881 0.96 CASP1 (0.55) CASP1CASP7HSD17B10SRD5A1SRD5A2
Aluminum Chloride Anhydrous SCHEMBL28688879 0.94 CASP1 (0.53) CASP1CASP7HSD17B10SRD5A1SRD5A2
Acetic Acid SCHEMBL28550221 0.89 SRD5A1 (0.58) CASP1CASP7HSD17B10SRD5A1SRD5A2
SCHEMBL1798900 0.88 MAOA (0.67) CASP1CASP7HSD17B10SRD5A1SRD5A2
SCHEMBL5108894 0.88 MAOA (0.61) CASP1CASP7HSD17B10SRD5A1SRD5A2
Tetrahydrofuran SCHEMBL28740997 0.88 SRD5A1 (0.49) CASP1CASP7HSD17B10SRD5A1SRD5A2
Formic Acid Methyl Ester SCHEMBL28686517 0.86 CASP1 (0.46) CASP1CASP7HSD17B10SRD5A1SRD5A2
SCHEMBL2601324 0.84 METAP1 (0.60) SRD5A1SRD5A2HTTMETAP1VHL
SCHEMBL1746656 0.84 HSD17B1 (0.69) CASP1CASP7HSD17B10SRD5A1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 799 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250042831-A1 PROCESS FOR PREPARING 5-CHLORO-2, 3-DIHYDRO-1H-INDEN-1-ONE ADAMA MAKHTESHIM LTD. (IL) 2025-02-06 US claimed
EP-4444690-A1 PROCESS FOR PREPARING 5-CHLORO-2, 3-DIHYDRO-1H-INDEN-1-ONE ADAMA MAKHTESHIM LTD. (IL) 2024-10-16 EP claimed
CN-118591521-A Process for preparing 5-chloro-2, 3-dihydro-1H-inden-1-one 安道麦马克西姆有限公司 2024-09-03 CN claimed
CN-117430489-A Preparation method of 5-chloro-1-indenone 山东京博生物科技有限公司 2024-01-23 CN claimed
WO-2023102721-A1 PROCESS FOR PREPARING 5-CHLORO-2, 3-DIHYDRO-1H-INDEN-1-ONE ADAMA MAKHTESHIM LTD. (IL) 2023-06-15 WO claimed
CN-115974664-A Synthesis method of 5-chloro-1-indanone 合肥工业大学 2023-04-18 CN claimed
CN-114105972-B Cinchonine derivative and application thereof in preparation of high-optical-purity indoxacarb intermediate 安徽广信农化股份有限公司 2022-12-23 CN claimed
CN-113861113-B Preparation and application of fused ring pyridine compound and derivative thereof 中国科学院福建物质结构研究所 2022-12-06 CN claimed
CN-113527075-B Preparation method for synthesizing 5-chloro-1-indanone by one-step method 佳尔科生物科技南通有限公司 2022-10-21 CN claimed
CN-111454137-B Synthetic method for improving yield of 5-chloro-1-indanone 山东京博生物科技有限公司 2022-09-23 CN claimed
US-20160332016-A1 Fire Extinguishing Composition Comprising Aldoketones Compound NANO FIRE, LLC 2016-11-17 US claimed
US-9309165-B2 6-chloro-3-(phenyl-d5)-inden-1-one and use thereof H. LUNDBECK A/S (DK) 2016-04-12 US claimed
US-20150336867-A1 6-chloro-3-(phenyl-d5)-inden-1-one and use thereof H. LUNDBECK A/S (DK) 2015-11-26 US claimed
EP-2943460-A2 6-CHLORO-3-(PHENYL-D5)-INDEN-1-ONE AND USE THEREOF H. Lundbeck A/S (DK) 2015-11-18 EP claimed
WO-2014096151-A2 6-CHLORO-3-(PHENYL-D5)-INDEN-1-ONE AND USE THEREOF H. LUNDBECK A/S (DK) 2014-06-26 WO claimed
WO-2000043342-A1 METHOD FOR PRODUCING A INDANONE OR THIOINDANONE TYPE COMPOUND RHODIA CHIMIE (FR) 2000-07-27 WO claimed
EP-0800500-B1 A PROCESS FOR PREPARING 5-CHLORO-2,3-DIHYDRO-1H-INDEN-1-ONE DU PONT (US) 1999-06-02 EP claimed
US-5811585-A CONTACTING 3-CHLORO-1-/4-CHLOROPHENYL/-1-PROPANOL WITH ACID CATALYST E. I. DU PONT DE NEMOURS AND COMPANY (US) 1998-09-22 US claimed
EP-0800500-A1 A PROCESS FOR PREPARING 5-CHLORO-2,3-DIHYDRO-1H-INDEN-1-ONE E.I. DU PONT DE NEMOURS AND COMPANY (US) 1997-10-15 EP claimed
WO-1996020151-A1 A PROCESS FOR PREPARING 5-CHLORO-2,3-DIHYDRO-1H-INDEN-1-ONE E.I. DU PONT DE NEMOURS AND COMPANY (US) 1996-07-04 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250042831-A1 PROCESS FOR PREPARING 5-CHLORO-2, 3-DIHYDRO-1H-INDEN-1-ONE SI, IDO1, CYP4B1 CASP1 978/4885CASP7 3553/4885HSD17B10 958/4885
US-20150336867-A1 6-chloro-3-(phenyl-d5)-inden-1-one and use thereof CYP2D6, UGT1A6, IDO1 CASP1 1810/4885CASP7 1866/4885HSD17B10 1913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.